Literature DB >> 17500067

Mechanistic studies of MDM2-mediated ubiquitination in p53 regulation.

Christopher L Brooks1, Muyang Li, Wei Gu.   

Abstract

As a central regulator for cell cycle arrest, apoptosis, and cellular senescence, p53 requires multiple layers of regulatory control to ensure correct temporal and spatial functions. It is well accepted that Mdm2-mediated ubiquitination plays a crucial role in p53 regulation. In addition to proteasome-mediated degradation, ubiquitination of p53 by Mdm2 acts a key signal for its nuclear export. Nuclear export has previously been thought to require the disassociation of the p53 tetramer and exposure of the intrinsic nuclear export signal. To elucidate the molecular mechanism of degradation-independent repression on p53 by Mdm2, we have developed a two-step approach to purify ubiquitinated forms of p53 induced by Mdm2 from human cells. Surprisingly, however, we found that ubiquitination has no effect on the tetramerization/oligomerization of p53, arguing against this seemingly well accepted model. Moreover, nuclear export of p53 alone is not sufficient to completely abolish p53 activity. Ubiquitination-mediated repression of p53 by Mdm2 acts at least, in part, through inhibiting the sequence-specific DNA binding activity. Thus, our results have important implications regarding the mechanisms by which Mdm2 acts on p53.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17500067      PMCID: PMC3737768          DOI: 10.1074/jbc.M700961200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

Review 2.  Substrate targeting in the ubiquitin system.

Authors:  J D Laney; M Hochstrasser
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

3.  The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression.

Authors:  Neri Minsky; Moshe Oren
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

Review 4.  Signaling through monoubiquitination.

Authors:  S Sigismund; S Polo; P P Di Fiore
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

5.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

6.  A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells.

Authors:  Nicoleta C Arva; Tamara R Gopen; Kathryn E Talbott; Latoya E Campbell; Agustin Chicas; David E White; Gareth L Bond; Arnold J Levine; Jill Bargonetti
Journal:  J Biol Chem       Date:  2005-05-20       Impact factor: 5.157

Review 7.  p53 ubiquitination: Mdm2 and beyond.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

8.  Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.

Authors:  W Tao; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Authors:  Delin Chen; Ning Kon; Muyang Li; Wenzhu Zhang; Jun Qin; Wei Gu
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

10.  A function for monoubiquitination in the internalization of a G protein-coupled receptor.

Authors:  J Terrell; S Shih; R Dunn; L Hicke
Journal:  Mol Cell       Date:  1998-01       Impact factor: 17.970

View more
  19 in total

1.  Ku70 is stabilized by increased cellular SUMO.

Authors:  Vyacheslav Yurchenko; Zhu Xue; Vivian Gama; Shigemi Matsuyama; Moshe J Sadofsky
Journal:  Biochem Biophys Res Commun       Date:  2007-12-04       Impact factor: 3.575

2.  MSL2 promotes Mdm2-independent cytoplasmic localization of p53.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  J Biol Chem       Date:  2008-11-25       Impact factor: 5.157

Review 3.  No Splicing, no dicing: non-proteolytic roles of the ubiquitin-proteasome system in transcription.

Authors:  Thomas Kodadek
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

4.  Inhibition of p53 DNA binding function by the MDM2 protein acidic domain.

Authors:  Brittany Cross; Lihong Chen; Qian Cheng; Baozong Li; Zhi-Min Yuan; Jiandong Chen
Journal:  J Biol Chem       Date:  2011-03-17       Impact factor: 5.157

5.  MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.

Authors:  Kristine M Wadosky; Jessica M Berthiaume; Wei Tang; Makhosi Zungu; Michael A Portman; A Martin Gerdes; Monte S Willis
Journal:  J Mol Endocrinol       Date:  2016-02-09       Impact factor: 5.098

6.  Nitration of the tumor suppressor protein p53 at tyrosine 327 promotes p53 oligomerization and activation.

Authors:  Vasily A Yakovlev; Alexander S Bayden; Paul R Graves; Glen E Kellogg; Ross B Mikkelsen
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

Review 7.  The multiple levels of regulation by p53 ubiquitination.

Authors:  J T Lee; W Gu
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

8.  A two-step mechanism for cell fate decision by coordination of nuclear and mitochondrial p53 activities.

Authors:  Xiao-Jun Tian; Feng Liu; Xiao-Peng Zhang; Jun Li; Wei Wang
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

9.  Logical network of genotoxic stress-induced NF-κB signal transduction predicts putative target structures for therapeutic intervention strategies.

Authors:  Rainer Poltz; Raimo Franke; Katrin Schweitzer; Steffen Klamt; Ernst-Dieter Gilles; Michael Naumann
Journal:  Adv Appl Bioinform Chem       Date:  2009-12-03

10.  p53 and Ceramide as Collaborators in the Stress Response.

Authors:  Rouba Hage-Sleiman; Maria O Esmerian; Hadile Kobeissy; Ghassan Dbaibo
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.